T1	Participants 210 306	patients under antihypertensive treatment visit-to-visit (or long-term) variability of clinic BP
T2	Participants 721 807	hypertensive patients of the European Lacidipine Study on Atherosclerosis (ELSA) trial
T3	Participants 1314 1421	Patients in whom at least seven clinic (6-month intervals) or at least three (yearly intervals) 24-h values
